history
The Facts

34 Independent Companies and/or Funds of which VB Founded,
or were Founding Investors.1

17 Technology Companies

Woven Orthopedics Technologies, LLC (2013) Founder
FX Solutions S.A.S. (2010) Early-stage Investor
AFCell Medical, Inc. (2009) Early-stage Investor
Centinel Spine, LLC (2008) Founder
Knee Creations, LLC (2007) Founder
4th Dimension Spine, LLC (2007) Founder
Small Bone Innovations, Inc. (2005) Founder
Paradigm Spine, LLC (2005) Founder
Soteira, Inc. (2004) Angel Investor
K2M, Inc. (2004) Early-stage Investor
Twin Star Medical, Inc. (2000) Angel Investor
Spine Solutions, Inc. (1999) Founder
Spine Next, S.A. (1999) Restructuring
Ascent Healthcare Solutions, Inc. (Formerly Alliance Medical, Inc.) 1998 Early-stage Investor
Cortek, Inc. (1995) Angel Investor
Hospitec, Inc. (1995) Early-stage Investor
Biorthex, Inc. (1993) Recapitalization

10 Private & Public Funds2

Managed by Stifel, Nicolaus & Company, Inc Viscogliosi Brothers Venture Partners III, LLC (2010) Musculoskeletal Growth Trust Series Unit Investment Trust (UIT) (2004)
Viscogliosi Brothers Venture Partners IV, LLC (2010) Viscogliosi Brothers Venture Partners II, LLC (2002)
Spinal Partners III, LLC (2010) Viscogliosi Brothers Venture Partners I, LLC (2001)
Small Bone Joint Employee Partners, LP (2005) Spine Solutions Partners I, LLC (2001)
Orthopedic Investment Partners Fund, L.P. (2004) Spinal Partners II, LLC (1999)

To date the 6 private funds have returned >$65 million to investors.


6 Professional Services Companies

Specialty Healthcare Advisers, LLC (2013) Surgisoft, LLC (2006)
VB Professional Services, Inc. (2010) Fillit, LLC (2006)
Orthopedic Recruiters, LLC (2008) Musculoskeletal Clinical Regulatory Advisers, LLC (2004)

1 Investment Banking Company

Viscogliosi & Company, LLC. (2004)

9 Exits to Date Generating > $1 billion in Exit Proceeds.3

Knee Creations, Inc. – Acquired by Zimmer, Inc. in May 2013 Cortek, Inc. ($7.9 million) – Acquired by Alphatec Spine, Inc. in Sept. 2005
Sotiera, Inc ($6 million) – Acquired by Globus Medical, Inc. in July 2012 Spine Next, S.A. ($80 million) – Acquired by Abbott Laboratories, Inc. in Oct. 2004
K2M, Inc.– Acquired by Welsh, Carson, Anderson & Stowe in July 2010 Spine Solutions, Inc. ($350 million) – Acquired by Synthes, Inc. in April 2003
Ascent Healthcare Solutions, Inc. ($565 million) – Acquired by Stryker Corp. in Nov 2009 Hospitec, Inc. – Payment to SPII Fund in Oct. 2001
Biorthex, Inc. ($0.20 million) – Acquired by Nitinol Devices & Components, Inc. in Aug. 2009

A Principal of VB has Structured and Managed Stifel Nicolaus’ $10 Million Musculoskeletal Growth Trust Series Unit Investment Trust (“UIT”).

Dedicated Exclusively to Investing in
Publicly-Traded Orthopedic Securities
24% 4 Year Annual Returns Compared to Dow Jones Industrial Average

40 Institutional Investors have Co-Invested with VB in Portfolio Company Financings.

250 Finance Transactions: 4

116 Merchant Banking Transactions 56 Assets Management Transactions
38 Investment Banking
(M&A/Strategic Advisory)
28 Exits/Realization
33 Equity/Debt Investments 17 Funds Investments
17 Exits/Realization 9 Venture/Private Equities
11 Principal Activities 
(Company Creations/Financial Founders)
2 Public Securities
11 Corporate Transactions 83 Portfolio Companies Transactions
10 Contribution of Assets 47 Small Bone Innovations, Inc.
18 Paradigm Spine, LLC
5 Viscogliosi & Company, Inc.
10 Knee Creations, Inc.
3 Centinel Spine, LLC

VB Has Served on Boards of 14 Institutions:

9 Orthopedic Devices Companies
4 Non-Device Companies
1 Specialty Hospital

Attended > 200 Industry Leading Conferences Worldwide:

Hosted >11 Conferences Dedicated Exclusively
to the Musculoskeletal Healthcare Sector

84 Orthopedic Devices have been Commercialized by VB Portfolio Companies: 5

>225,000 Units are Sold Worldwide

932 Industry and Company Reports have been Written by VB, of which >7,000 Pages have been Published.

>250 Individuals are Currently Employed in VB Portfolio Companies

Since Inception [2004], Musculoskeletal Clinical Regulatory Advisers, LLC has Contracted Approximately >270 Clients to Date.

The MCRA team has achieved:
  • 1,000 510(k)s protocols written, submitted and reviewed Orthopedic Devices have Received 510(k) Approval from the FDA
  • 75 Investigational Device Exemption (IDE)
  • 14 Pre-Marketing Approval (PMA) were obtained
Performed or developed >700 Health Economics, Reimbursement, Public Policy and related activities.
>400 Patents have been granted and >240 Trademarks were registered by the United States Patent and Trademark Office

Performed >210 Audits for Notified Body (TÜV Product Service) to ISO 9001 / ISO 13485 Including Numerous Audits at Leading Orthopedic Companies






   

1Viscogliosi Bros., LLC (VB) considers itself a founder of a company if VB and/or its principals a) formed the company, b) was an early-stage or angel investor of the company and was involved in the 
early operations and/or strategy of the company, or c) involved in the recapitalization of the company.

2All funds with the exception for UIT were created by VB. A principal of VB was an employee (portfolio manager) of Stifel Nicolaus, raised capital, selected investments/ratios and advised on the sale of securities for the company. Subsequent to VB, the principal continued his advisement on the sale of securities for Stifel Nicolaus.

3 A total dollar value, including milestone payments, paid for an entity sold by VB, its principals, and/or VB's funds.

4Includes any form of corporate transactions that include a) capital raising activities, b) contribution of assets, c) acquisition/divestitures of an assets (M&A), d) investment banking services, & e) company creation.

5Medical devices that are commercially sold or clinically used worldwide.